INTRODUCTION AND OBJECTIVES:
Several studies evaluated the role of traditional training and exposure to certain volumes of multiparametric MRI (MRI) to optimize the detection of clinically significant prostate cancer (csPCa). However, these reports did not provide an insight whether mpMRI performed in Academic vs non-Academic Centres might influence the detection of csPCa at targeted biopsy (TBx). Academic center profile may be indeed considered a proxy for increased adherence to validated standards of quality.
METHODS: We relied on a cohort of 494 men with positive MRI (PIRADS!3) who underwent targeted and concomitant systematic biopsy at a single tertiary referral Center between 2013 and 2018. Overall, 318 (64%) patients received a pre-biopsy mpMRI at a single Academic Centre, while 176 (36%) at different non-Academic Centers. All prostate biopsies were performed at our Institution by two expert urologists. The study outcome was csPCa at targeted cores, defined as Gleason score at targeted prostate biopsy!3þ4. Multivariable logistic regression analysis (MVA) was performed to assess the relationship between mpMRI performed and interpreted at Academic vs. non-Academic Centers and the study outcome, after accounting for age at MRI, PSA (ng/ml), prostate volume (ml), number of MRI lesions, volume of the index lesion, number of target cores and biopsy history (naive vs. previous biopsy).
RESULTS: Overall, csPCa detection at TBx was 48% (n[237). When stratifying according to Institution profile, TBx detected 53% (n[167) of csPCa when MRI was performed at Academic Center vs 40% (n[70) when MRI was done in non-Academic Centers (p[0.03). Interestingly, no statistically significant differences in terms of PSA, age at biopsy, prostate volume, volume of the lesion, number of MRI lesions, number of targeted samples, PI-RADS score and previous biopsy status was observed between patients imaged at Academic vs. non-Academic centres (all p>0.09).The median number of targeted cores was 3 in both groups. At MVA, Academic Centre (OR: 1.8), age at biopsy (OR: 1.08), prostate volume (0.9) and number of targeted cores (OR: 1.2) were independent predictors of csPCa at targeted biopsy (all p 0.03) CONCLUSIONS: We demonstrated that MRI performed at Academic Centre is associated with roughly a 2-fold higher probability of finding csPCa at targeted biopsy even after accounting for all confounders.These findings strongly reinforce the need for adequate imaging evaluation and possible central re-assessment in order to maximize the ability to detect csPCa in case of a positive mpMRI. (Table 2) .
CONCLUSIONS: Meta-analyses suggests that the MRIpathway has a more favourable diagnostic accuracy for detecting prostate cancer than standard biopsy. Prostate MRI, with or without targeted biopsy, increases the detection of GG!2 PCa and reduces both GG[1 PCa overdiagnosis and biopsy procedures. This argues for an MRI-directed biopsy management in all men, including biopsynaive men.
